[1] Shell S,Park SM,Radjabi AR,et al.Let-7 expression defines two differentiation stages of cancer[J].Proc Natl Acad Sci U S A,2007,104(27):11400-11405.
[2] Califano D,Pignata S,Losito NS,et al.High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer[J].J Cell Physiol,2014,229(1):53-59.
[3] Kong D,Su G,Zha L,et al.Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer[J].Med Oncol,2014,31(8):130.
[4] Takamizawa J,Konishi H,Yanagisawa K,et al.Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival[J].Cancer Res,2004,64(11):3753-3756.
[5] Inamura K,Togashi Y,Nomura K,et al.Let-7 microRNA expression is reduced in bronchioloalveolar carcinoma,a non-invasive carcinoma,and is not correlated with prognosis[J].Lung Cancer,2007,58(3):392-396.
[6] 严晓梅,冯一中,胥传海,等.微RNAlet7、高迁移率族蛋白在非小细胞肺癌中的表达及临床意义[J].江苏医药,2011,37(3):294-297.
[7] 杨大运,齐战,高少伟,等.HMGA2和RKIP在非小细胞肺癌中的表达及其相关性[J].现代预防医学,2015,9:1673-1676.
[8] Xia Y,Zhu Y,Zhou X,et al.Low expression of let-7 predicts poor prognosis in patients with multiple cancers:a Meta-analysis[J].Tumour Biol,2014,35(6):5143-5148.
[9] Blom IE,Goldschmeding R,Leask A.Gene regulation of connective tissue growth factor:new targets for antifibrotic therapy?[J].Matrix Biol,2002,21(6):473-482.
[10] Zhou ZR,Zhang T,Li B.Extracting and transforming of appropriate data of Meta-analysis in survival curve[J].Chin J Evid Based Cardiovasc Med,2014,6:3.
[11] Nair VS,Maeda LS,Ioannidis JP.Clinical outcome prediction by microRNAs in human cancer:a systematic review[J].Nair VS,2012,104(7):528-540.
[12] Voortman J,Goto A,Mendiboure J,et al.MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma[J].Cancer Res,2010,70(21):8288-8298.
[13] Zhao B,Han H,Chen J,et al.MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3[J].Cancer Lett,2014,342(1):43-51.
[14] Droge P,Davey CA.Do cells let-7 determine stemness?[J].Cell Stem Cell,2008,2(1):8-9.
[15] Mayr C,Hemann MT,Bartel DP.Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation[J].Science,2007,315(5818):1576-1579.
[16] He XY,Chen JX,Zhang Z,et al.The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice[J].J Cancer Res Clin Oncol,2010,136(7):1023-1028.
[17] Trang P,Wiggins JF,Daige CL,et al.Systemic delivery of tumor suppressor microRNA mimics using a nutral lipid emulsion inhibits lung tumors in mice[J].Mol Ther,2011,19(6):1116-1122.
[18] Helmke BM,Markowski DN,Meyer A,et al.The expression of HMGA2 varies strongly among colon carcinomas[J].Anticancer Res,2012,32(5):1589-1593.
[19] Muller MH,Drieschner N,Focken T,et al.HMGA2 expression in the PC-3 prostate cancer cell line is autonomous of growth factor stimulation[J].Anticancer Res,2013,33(8):3069-3078.
[20] Sun M,Song CX,Huang H,et al.HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis[J].Proc Natl Acad Sci U S A,2013,110(24):9920-9925.
[21] Kumar MS,Armenteros-Monterroso E,East P,et al.HMGA2 functions as a competing endogenous RNA to promote lung cancer progression[J].Nature,2014,505(7482):212-217.
[22] Rice SJ,Lai SC,Wood LW,et al.MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1(TTF-1/NKX2-1)[J].J Biol Chem,2013,288(23):16348-16360.
[23] Winslow MM,Dayton TL,Verhaak RG,et al.Suppression of lung adenocarcinoma progression by Nkx2-1[J].Nature,2011,473(7345):101-104.
[24] Xia XM,Jin WY,Shi RZ,et al.Clinical significance and the correlation of expression between Let-7 and K-ras in non-small cell lung cancer[J].Oncol Lett,2010,1(6):1045-1047.
[25] Landi MT,Zhao Y,Rotunno M,et al.MicroRNA expression differentiates histology and predicts survival of lung cancer[J].Clin Cancer Res,2010,16(2):430-441.
[26] Zhang YK,Zhu WY,He JY,et al.MiRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes[J].J Cancer Res Clin Oncol,2012,138(10):1641-1650.
[27] Yanaihara N,Caplen N,Bowman E,et al.Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J].Cancer Cell,2006,9(3):189-198.
[28] Jusufovic E,Rijavec M,Keser D,et al.let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non-small-cell lung cancer[J].PLoS One,2012,7(9):e45577.
[29] Capodanno A,Boldrini L,Proietti A,et al.Let-7g and miR-21 expression in non-small cell lung cancer:correlation with clinicopathological and molecular features[J].Int J Oncol,2013,43(3):765-774.
[30] 兰芬,熊盛道,熊维宁,等.非小细胞肺癌中HMGA2的表达与细胞增殖的关系[J].中国组织化学与细胞化学杂志,2008,17(5):416-420.
[31] 刘晓静,赵伟,张庆宪.HMGA2、MMP2在非小细胞肺癌中的表达及临床意义[J].中国老年学杂志,2011,31(2):209-211.
[32] 肖晓辉,刘华,高婧.高迁移率族蛋白A2和肿瘤转移抑制基因在非小细胞肺癌组织的表达及临床意义[J].临床荟萃,2013,28(2):138-140.
[33] Meyer B,Loeschke S,Schultze A,et al.HMGA2 overexpression in non-small cell lung cancer[J].Mol Carcinog,2007,46(7):503-511.
[34] Wu Y,Song Y,Liu H.Expression and its clinical significance of HMGA2 in the patients with non-small cell lung cancer[J].Chin J Lung Cancer,2008,11(3):377-381.
[35] Eide HA,Halvorsen AR,Bjaanaes MM,et al.The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma-differences in histological subtypes[J].BMC Cancer,2015,16(1):71.
[36] Sarhadi VK,Wikman H,Salmenkivi K,et al.Increased expression of high mobility group A proteins in lung cancer[J].J Pathol,2006,209(2):206-212. |